...
首页> 外文期刊>Radiation Oncology Journal >Malignant Fibrous Histiocytoma of the Maxilla: Report of A case
【24h】

Malignant Fibrous Histiocytoma of the Maxilla: Report of A case

机译:上颌骨恶性纤维组织细胞瘤1例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Malignant fibrous histiocytoma(MFH) of the maxilla is a rare malignant bone tumor. Seven percents of all MFH occur in the head and neck. Approximately 12% of these tumors occur in the maxilla. Local recurrence or distant metastasis was reported in 55% of cases of maxillary MFH. The mean survival time of 30 months was reported from a review of 14 MFHs in he masxilla, mandible and oral soft tissues. MFH of the maxilla is best treated surgically but radical neck dissection dose not appear to be indicated unless there is clinical evidence of lymph node metastases. Although the use of radiation therapy for head and neck MFH has not been studied for a series of cases, individual cases of regression or histological change have been reported. Other authors have reported numbers of cases who received radiation therapy without benefit. Response to combination chemotherapy has been reported in 33% of 23 patients with recurrent or metastatic MFH. We report here a case of MFH occurring in the maxilla with a review of literature about the clinical behavior and treatment of these lesions.
机译:上颌的恶性纤维组织细胞瘤(MFH)是一种罕见的恶性骨肿瘤。 MFH的百分之七发生在头和颈部。这些肿瘤中约有12%发生在上颌骨。在55%的上颌MFH病例中报告了局部复发或远处转移。通过对14个MFHs在下颌,下颌骨和口腔软组织中的复查报告,平均生存时间为30个月。上颌骨的MFH最好通过外科手术治疗,但除非有临床证据表明有淋巴结转移,否则不建议行根治性颈淋巴结清扫术。尽管尚未针对一系列病例研究使用放射疗法治疗头颈部MFH,但已报道了个别情况发生回归或组织学改变。其他作者报告了接受放射疗法无益的病例数。在23例复发或转移性MFH患者中,有33%报道了对联合化疗的反应。我们在此报告了上颌骨发生MFH的病例,并回顾了有关这些病变的临床行为和治疗的文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号